Xarelto (rivaroxaban)

pCPA File Number: 20822

Negotiation Status:

Concluded with an LOI

Indication(s):

Thromboembolic events (venous), pulmonary embolism

Sponsor/Manufacturer:

Bayer Inc.

CADTH Project Number:

SR0327

pCPA Engagement Letter Issued:

2014-05-28

Negotiation Process Concluded:

2014-07-29